Medtronic's CRT-Ds were most likely to fail 1st in a pair of head-to-head studies comparing the devices to rival implants from Boston Scientific, Biotronik and St. Jude Medical.
News Well, Clinical Trials, Cardiac Implants, Cardiac Rhythm Management, Conference coverage, HRS 2014
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1ouyINf
Cap comentari:
Publica un comentari a l'entrada